Top 5 Takeaways Increased TB Case Counts Across All Groups: In 2023, the U.S. saw an increase in tuberculosis (TB) cases across all age groups, U.S.-born and non-U.S.–born persons, and
Tag: Infectious Disease
Top 5 Takeaways Increased Detection of Measles Vaccine Virus: Approximately 1% of syndromic PCR panels conducted by a commercial laboratory tested positive for measles, mainly in children recently vaccinated against
Top 5 Takeaways Growing resistance: The prevalence of antibiotic-resistant strains of Neisseria gonorrhoeae, particularly to ceftriaxone, has significantly increased in China from 2017 to 2022, with resistance to ceftriaxone approximately
Top 5 Takeaways Exemption for Certain Pediatric Transplant Candidates: Children under 12 years old who have undergone postnatal infectious disease testing are now exempt from pretransplant testing for HIV, HBV,
Top 5 Takeaways Widespread Provider Availability: As of April 25, 2022, 87.5% of U.S. counties had at least one active COVID-19 vaccine provider for children aged 5–11, primarily pharmacies and
Top 5 Takeaways Immunocompromised patients represented a significant portion of COVID-19 hospitalizations. Accounting for 12.2% of adult COVID-19 hospitalizations across 10 states, immunocompromised patients had increased odds of ICU admission
Top 5 Takeaways Significant Scale-Up in TB Preventive Treatment: From October 2016 to October 2023, about 13 million ART clients completed Tuberculosis Preventive Treatment (TPT) across 36 countries supported by
Top 5 Takeaways Significant Decrease in HIV Testing and Case Identification: The first months of the COVID-19 pandemic saw a 40.1% decrease in HIV testing and a 29.4% decrease in
Top 5 Takeaways Variability in Case Definitions: The report highlights the significant variation in toxoplasmosis case definitions across six states, affecting disease estimates and comparisons. Challenges in Surveillance: Identifying newly
Top 5 Takeaways Vaccine Effectiveness (VE) varies with dose number and Omicron sublineage. VE was generally lower during the Omicron BA.2/BA.2.12.1 period compared to the BA.1 period. A third dose